Reuters logo
BRIEF-Paratek Pharma antibiotic granted additional qualified infectious disease product designation by FDA​
September 21, 2017 / 12:11 PM / a month ago

BRIEF-Paratek Pharma antibiotic granted additional qualified infectious disease product designation by FDA​

Sept 21 (Reuters) - Paratek Pharmaceuticals Inc

* Paratek Pharmaceuticals Inc - its antibiotic omadacycline has been granted additional qualified infectious disease product designation by U.S. FDA​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below